{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:46:44Z","timestamp":1791283604076,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T00:00:00Z","timestamp":1428278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T00:00:00Z","timestamp":1428278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/cmi.2015.25","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T11:14:39Z","timestamp":1428405279000},"page":"309-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Xiangsheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengsheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,6]]},"reference":[{"key":"BFcmi201525_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"European Association for the Study of the Liver","year":"2012","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167\u2013185.","journal-title":"J Hepatol"},{"key":"BFcmi201525_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/egh.09.50","volume":"3","author":"FS Wang","year":"2009","unstructured":"Wang FS, Zhang Z . Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Rev Gastroenterol Hepatol 2009; 3: 499\u2013512.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"BFcmi201525_CR3","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.24249","volume":"53","author":"A Schurich","year":"2011","unstructured":"Schurich A, Khanna P, Lopes AR et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011; 53: 1494\u20131503.","journal-title":"Hepatology"},{"key":"BFcmi201525_CR4","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","volume":"61","author":"A Bertoletti","year":"2011","unstructured":"Bertoletti A, Ferrari C . Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2011; 61: 1754\u20131764. doi:10.1136\/gutjnl-2011-301073.","journal-title":"Gut"},{"key":"BFcmi201525_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1440-1746.2011.06940.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhang JY, Wang LF, Wang FS . Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatology 2012; 27: 223\u2013230.","journal-title":"J Gastroenterol Hepatology"},{"key":"BFcmi201525_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/jhep.2003.50035","volume":"37","author":"CM Lo","year":"2003","unstructured":"Lo CM, Fung JT, Lau GK et al. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B. Hepatology 2003; 37: 36\u201343.","journal-title":"Hepatology"},{"key":"BFcmi201525_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/lt.20887","volume":"13","author":"Y Luo","year":"2007","unstructured":"Luo Y, Lo CM, Cheung CK, Lau GK, Fan ST, Wong J . Identification of hepatitis B virus-specific lymphocytes in human liver grafts from HBV-immune donors. Liver Transpl 2007; 13: 71\u201379.","journal-title":"Liver Transpl"},{"key":"BFcmi201525_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-2893.2003.00391.x","volume":"10","author":"U Dahmen","year":"2003","unstructured":"Dahmen U, Li J, Dirsch O et al. Adoptive transfer of donor-derived immunity by liver transplantation: a potential avenue to prevent hepatitis B virus reinfection. J Viral Hepat 2003; 10: 31\u201336.","journal-title":"J Viral Hepat"},{"key":"BFcmi201525_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/TP.0b013e31818bfc85","volume":"87","author":"A Schumann","year":"2009","unstructured":"Schumann A, Lindemann M, Valentin-Gamazo C et al. Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients. Transplantation 2009; 87: 103\u2013111.","journal-title":"Transplantation"},{"key":"BFcmi201525_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1056\/NEJM200101043440120","volume":"344","author":"I Dervite","year":"2001","unstructured":"Dervite I, Hober D, Morel P . Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 2001; 344: 68\u201369.","journal-title":"N Engl J Med"},{"key":"BFcmi201525_CR11","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1182\/blood-2003-05-1403","volume":"102","author":"TH Westhoff","year":"2003","unstructured":"Westhoff TH, Jochimsen F, Schmittel A et al. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 2003; 102: 1930.","journal-title":"Blood"},{"key":"BFcmi201525_CR12","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/sj.leu.2403914","volume":"19","author":"P Niscola","year":"2005","unstructured":"Niscola P, Del Principe MI, Maurillo L et al. Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy. Leukemia 2005; 19: 1840\u20131841.","journal-title":"Leukemia"},{"key":"BFcmi201525_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","volume":"27","author":"W Yeo","year":"2009","unstructured":"Yeo W, Chan TC, Leung NW et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009; 27: 605\u2013611.","journal-title":"J Clin Oncol"},{"key":"BFcmi201525_CR14","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1172\/JCI116497","volume":"91","author":"T Maruyama","year":"1993","unstructured":"Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR . The serology of chronic hepatitis B infection revisited. J Clin Invest 1993; 91: 2586\u20132595.","journal-title":"J Clin Invest"},{"key":"BFcmi201525_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1365-2249.1996.d01-732.x","volume":"105","author":"WO Bocher","year":"1996","unstructured":"Bocher WO, Herzog-Hauff S, Herr W et al. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 1996; 105: 52\u201358.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi201525_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","volume":"55","author":"B Oliviero","year":"2011","unstructured":"Oliviero B, Cerino A, Varchetta S et al. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. J Hepatol 2011; 55: 53\u201360.","journal-title":"J Hepatol"},{"key":"BFcmi201525_CR17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1172\/JCI110860","volume":"71","author":"GM Dusheiko","year":"1983","unstructured":"Dusheiko GM, Hoofnagle JH, Cooksley WG, James SP, Jones EA . Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest 1983; 71: 1104\u20131113.","journal-title":"J Clin Invest"},{"key":"BFcmi201525_CR18","first-page":"259","volume":"60","author":"V Barnaba","year":"1985","unstructured":"Barnaba V, Valesini G, Levrero M et al. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Clin Exp Immunol 1985; 60: 259\u2013266.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi201525_CR19","first-page":"283","volume":"70","author":"V Barnaba","year":"1987","unstructured":"Barnaba V, Levrero M, Ruberti G et al. In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients. Clin Exp Immunol 1987; 70: 283\u2013288.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi201525_CR20","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/infdis\/jir165","volume":"203","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Xu X, Lu J et al. B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation. J Infect Dis 2011; 203: 1668\u20131678.","journal-title":"J Infect Dis"},{"key":"BFcmi201525_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaci.2008.04.034","volume":"122","author":"S Moir","year":"2008","unstructured":"Moir S, Fauci AS . Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol 2008; 122: 12\u201319.","journal-title":"J Allergy Clin Immunol"},{"key":"BFcmi201525_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nri2524","volume":"9","author":"S Moir","year":"2009","unstructured":"Moir S, Fauci AS . B cells in HIV infection and disease. Nat Rev Immunol 2009; 9: 235\u2013245.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201525_CR23","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/BF02208991","volume":"40","author":"CM Chu","year":"1995","unstructured":"Chu CM, Sheen IS, Yeh CT, Hsieh SY, Tsai SL, Liaw YF . Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection. Dig Dis Sci 1995; 40: 2107\u20132112.","journal-title":"Dig Dis Sci"},{"key":"BFcmi201525_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1665-2681(19)32147-7","volume":"2","author":"M Gora-Gebka","year":"2003","unstructured":"Gora-Gebka M, Liberek A, Szydlowska-Lysiak W, Bako W, Korzon M . Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha. Ann Hepatol 2003; 2: 92\u201397.","journal-title":"Ann Hepatol"},{"key":"BFcmi201525_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jhep.2008.05.017","volume":"49","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Zou ZS, Fu JL et al. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J Hepatol 2008; 49: 396\u2013406.","journal-title":"J Hepatol"},{"key":"BFcmi201525_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.immunol.25.022106.141602","volume":"25","author":"LB Dustin","year":"2007","unstructured":"Dustin LB, Rice CM . Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 2007; 25: 71\u201399.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi201525_CR27","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.20072683","volume":"205","author":"S Moir","year":"2008","unstructured":"Moir S, Ho J, Malaspina A et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008; 205: 1797\u20131805.","journal-title":"J Exp Med"},{"key":"BFcmi201525_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/1743-422X-7-370","volume":"7","author":"C Wu","year":"2010","unstructured":"Wu C, Liu Y, Zhao Q et al. Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: a preliminary approach for anti-HBV immunotherapy. Virol J 2010; 7: 370.","journal-title":"Virol J"},{"key":"BFcmi201525_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","volume":"13","author":"FV Chisari","year":"1995","unstructured":"Chisari FV, Ferrari C . Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29\u201360.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi201525_CR30","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/0016-5085(93)90960-K","volume":"105","author":"T Maruyama","year":"1993","unstructured":"Maruyama T, Iino S, Koike K, Yasuda K, Milich DR . Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 1993; 105: 1141\u20131151.","journal-title":"Gastroenterology"},{"key":"BFcmi201525_CR31","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1128\/JVI.79.5.3038-3051.2005","volume":"79","author":"JJ Chang","year":"2005","unstructured":"Chang JJ, Wightman F, Bartholomeusz A et al. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J Virol 2005; 79: 3038\u20133051.","journal-title":"J Virol"},{"key":"BFcmi201525_CR32","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","volume":"191","author":"MK Maini","year":"2000","unstructured":"Maini MK, Boni C, Lee CK et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191: 1269\u20131280.","journal-title":"J Exp Med"},{"key":"BFcmi201525_CR33","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/jhep.2001.23045","volume":"33","author":"C Boni","year":"2001","unstructured":"Boni C, Penna A, Ogg GS et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33: 963\u2013971.","journal-title":"Hepatology"},{"key":"BFcmi201525_CR34","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.4049\/jimmunol.178.10.6634","volume":"178","author":"L Chen","year":"2007","unstructured":"Chen L, Zhang Z, Chen W et al. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol 2007; 178: 6634\u20136641.","journal-title":"J Immunol"},{"key":"BFcmi201525_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jhep.2010.01.014","volume":"52","author":"J Jaroszewicz","year":"2010","unstructured":"Jaroszewicz J, Calle SB, Wursthorn K et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010; 52: 514\u2013522.","journal-title":"J Hepatol"},{"key":"BFcmi201525_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2010.01.007","volume":"52","author":"T Nguyen","year":"2010","unstructured":"Nguyen T, Thompson AJ, Bowden S et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010; 52: 508\u2013513.","journal-title":"J Hepatol"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201525","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T06:17:02Z","timestamp":1672726622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFcmi201525"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2015.25","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,6]]},"assertion":[{"value":"3 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}